These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 28482228)
1. Classification systems in Gestational trophoblastic neoplasia - Sentiment or evidenced based? Parker VL; Pacey AA; Palmer JE; Tidy JA; Winter MC; Hancock BW Cancer Treat Rev; 2017 May; 56():47-57. PubMed ID: 28482228 [TBL] [Abstract][Full Text] [Related]
2. [Malignant trophoblastic tumors (MTT) treated in the years 1955-2004 in trophoblastic disease center in the Czech Republic (TDC-CZ): clinical-pathological features, curability, typing, pathogenesis]. Zavadil M; Feyereisl J; Safár P; Pán M Ceska Gynekol; 2004 Dec; 69 Suppl 1():9-15. PubMed ID: 15748020 [TBL] [Abstract][Full Text] [Related]
3. Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010. Agarwal R; Alifrangis C; Everard J; Savage PM; Short D; Tidy J; Fisher RA; Sebire NJ; Harvey R; Hancock BW; Coleman RE; Seckl MJ J Reprod Med; 2014; 59(1-2):7-12. PubMed ID: 24597279 [TBL] [Abstract][Full Text] [Related]
4. Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital. Xiao C; Yang J; Zhao J; Ren T; Feng F; Wan X; Xiang Y BMC Cancer; 2015 Apr; 15():318. PubMed ID: 25927660 [TBL] [Abstract][Full Text] [Related]
5. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13. Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171 [TBL] [Abstract][Full Text] [Related]
6. Dutch Risk Classification and FIGO 2000 for Gestational Trophoblastic Neoplasia Compared. Eysbouts YK; Massuger L; Thomas C; Ottevanger P; Short D; Harvey R; Sebire N; Kaur B; Naveed S; Sweep F; Seckl M Int J Gynecol Cancer; 2016 Nov; 26(9):1712-1716. PubMed ID: 27654257 [TBL] [Abstract][Full Text] [Related]
7. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid. Taylor F; Grew T; Everard J; Ellis L; Winter MC; Tidy J; Hancock BW; Coleman RE Eur J Cancer; 2013 Oct; 49(15):3184-90. PubMed ID: 23870384 [TBL] [Abstract][Full Text] [Related]
8. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level. Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295 [TBL] [Abstract][Full Text] [Related]
9. Changes in the management of high-risk gestational trophoblastic neoplasia in the National Trophoblastic Disease Center of Hungary. Fülöp V; Szigetvári I; Szepesi J; Végh G; Berkowitz RS J Reprod Med; 2014; 59(5-6):227-34. PubMed ID: 24937962 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia. Maestá I; Growdon WB; Goldstein DP; Bernstein MR; Horowitz NS; Rudge MV; Berkowitz RS Gynecol Oncol; 2013 Aug; 130(2):312-6. PubMed ID: 23707672 [TBL] [Abstract][Full Text] [Related]
11. The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate. Gilani MM; Fariba B; Behtash N; Ghaemmaghami F; Moosavi AS; Rezayof E J Cancer Res Ther; 2013; 9(1):38-43. PubMed ID: 23575072 [TBL] [Abstract][Full Text] [Related]
12. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset. Eysbouts YK; Ottevanger PB; Massuger LFAG; IntHout J; Short D; Harvey R; Kaur B; Sebire NJ; Sarwar N; Sweep FCGJ; Seckl MJ Ann Oncol; 2017 Aug; 28(8):1856-1861. PubMed ID: 28459944 [TBL] [Abstract][Full Text] [Related]
13. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Ngan HY Int J Gynecol Cancer; 2004; 14(2):202-5. PubMed ID: 15086715 [TBL] [Abstract][Full Text] [Related]